Cargando…
The mitochondrial genome as a modifier of autism versus cancer phenotypes in PTEN hamartoma tumor syndrome
Cancer and autism spectrum disorder/developmental delay (ASD/DD) are two common clinical phenotypes in individuals with germline PTEN variants (PTEN hamartoma tumor syndrome, PHTS). Burgeoning studies have shown that genomic and metabolomic factors may act as modifiers of ASD/DD versus cancer in PHT...
Autores principales: | Wei, Ruipeng, Yehia, Lamis, Ni, Ying, Eng, Charis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10193119/ https://www.ncbi.nlm.nih.gov/pubmed/37216009 http://dx.doi.org/10.1016/j.xhgg.2023.100199 |
Ejemplares similares
-
Integrating somatic CNV and gene expression in breast cancers from women with PTEN hamartoma tumor syndrome
por: Brewer, Takae, et al.
Publicado: (2023) -
Distinct metabolic profiles associated with autism spectrum disorder versus cancer in individuals with germline PTEN mutations
por: Yehia, Lamis, et al.
Publicado: (2022) -
The microbiome in PTEN hamartoma tumor syndrome
por: Byrd, Victoria, et al.
Publicado: (2017) -
Germline TTN variants are enriched in PTEN-wildtype Bannayan–Riley–Ruvalcaba syndrome
por: Yehia, Lamis, et al.
Publicado: (2017) -
Largescale population genomics versus deep phenotyping: Brute force or elegant pragmatism towards precision medicine
por: Yehia, Lamis, et al.
Publicado: (2019)